Glenmark, Granules Rally on US Drug Approvals
Glenmark and Granules India shares rose Monday, hitting fresh highs after both drugmakers landed key US regulatory approvals. Both moves were driven by news out...
Tag : Glenmark
Glenmark Pharma Inks Exclusive Licensing Agreement With Lotus International
Glenmark Pharmaceuticals Ltd said its Swiss arm has entered into an exclusive licensing agreement with Lotus International Pte Ltd for commercialising its innovative nasal spray...
Glenmark Pharmaceuticals Receives US FDA Approval
The US health regulator, US FDA, has approved Glenmark Pharmaceuticals Ltd’s Teriflunomide tablets, which used to treat multiple sclerosis into the US market. The approved...
Glenmark Pharma Profit For The June Quarter At Rs. 232.99 Crores
One of India’s largest pharmaceutical company, Glenmark Pharma, reported their net consolidated profit for the June-end quarter of the current fiscal year at Rs. 232.99...
Glenmark gets USFDA approval for generic versions of Loestrin tablets
Glenmark Pharmaceuticals has received final approval for generic versions of Loestrin tablets, from the US health regulator. In a BSE filing the company stated, “Glenmark Pharmaceuticals...
Glenmark gets USFDA nod for generic version of Temovate Topical
Glenmark Pharmaceuticals has received final approval for generic version of Temovate Topical Solution, from the US health regulator. It is used to treat certain scalp and skin...
Glenmark gets USFDA approval for skin ointment
Glenmark Pharmaceuticals has received final approval for Tacrolimus ointment, from the US health regulator. The ointment is used for treating atopic dermatitis (eczema). In a BSE...
Glenmark associates with Helsinn Group to launch Akynzeo
Glenmark Pharmaceuticals has signed a licensing agreement with Swiss based pharma, Helsinn Group for launch of Akynzeo in India and Nepal. This drug is used to...
Glenmark Pharma gets USFDA nod for Clobetasol Propionate Spray
Glenmark Pharmaceuticals Inc. USA has been given final approval by the United States Food & Drug Administration (USFDA), for Clobetasol Propionate Spray, 0.05%, the generic version...
Glenmark introduces biosimilar of Adalimumab
Glenmark Pharmaceuticals, for treating plaque psoriasis and rheumatoid arthritis in the country, has announced the launch of Adalimumab’s biosimilar under a licensing agreement with Zydus group firm...